Decrease in Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) Enhanced Disease with RSV G Glycoprotein Peptide Immunization in BALB/c Mice

Respiratory syncytial virus (RSV) is a high priority target for vaccine development. One concern in RSV vaccine development is that a non-live virus vaccine would predispose for enhanced disease similar to that seen with the formalin inactivated RSV (FI-RSV) vaccine. Since a mAb specific to RSV G pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Rey, Gertrud U., Miao, Congrong, Caidi, Hayat, Trivedi, Suvang U., Harcourt, Jennifer L., Tripp, Ralph A., Anderson, Larry J., Haynes, Lia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871585/
https://www.ncbi.nlm.nih.gov/pubmed/24376637
http://dx.doi.org/10.1371/journal.pone.0083075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871585/
https://www.ncbi.nlm.nih.gov/pubmed/24376637
http://dx.doi.org/10.1371/journal.pone.0083075

Ejemplares similares